Skip to main content
HR 790 114th Congress House Health Business records Civil actions and liability Drug safety, medical device, and laboratory regulation Drug therapy Health technology, devices, supplies Long-term, rehabilitative, and terminal care Prescription drugs Retail and wholesale trades Trade restrictions

Compassionate Freedom of Choice Act of 2015

Introduced: February 5, 2015 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2015
Referred to the Subcommittee on Health.
Feb 5, 2015
Referred to the House Committee on Energy and Commerce.
Feb 5, 2015
Introduced in House
 Plain-English summary Congressional Research Service

Compassionate Freedom of Choice Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) must not prevent or restrict, the manufacture, importation, distribution, or sale of investigational drugs or devices for terminally ill patients.

The FDA is prohibited from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA.

Except in cases of gross negligence or willful misconduct, any person who manufactures, imports, distributes, prescribes, or administers an investigational drug or device is not liable under state or federal law for loss, damage, or injury from: (1) the development, testing, production, acquisition, or use of such drugs or devices; or (2) their safety or effectiveness.

What's happening now February 6, 2015

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2